Video

Sacral neuromodulation shows efficacy in OAB patients with Parkinson’s disease

Author(s):

Urology Times staff

“Of those patients that did the test phase 82% of them actually went on to full implants,” says Sarah Martin, DO.

In this video, Sarah Martin, DO, discusses the background and key findings from the recent Neurourology & Urodynamics study, “Is sacral neuromodulation effective in patients with Parkinson's disease? A retrospective review,” for which she served as first author. Martin is an FPMRS fellow at Glickman Urological & Kidney Institute at Cleveland Clinic.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
DNA helix | Image Credit: © BillionPhotos.com - stock.adobe.com
Woman typing on laptop | Image Credit: © Gorodenkoff - stock.adobe.com
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Related Content
iTNM may provide comparable safety, efficacy to SNM for OAB, UUI
November 4th 2024

iTNM may provide comparable safety, efficacy to SNM for OAB, UUI

Hannah Clarke
The UUI responder rate was 71.8% among those who received SNM and 71.3% among those who received iTNM.
Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB
March 21st 2022

Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB

Urology Times staff
“This technique is feasible, it is very well tolerated, and there’s not much of a complication rate, so it appears to be very safe,” says Amy D. Dobberfuhl, MD, MS.
Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB
October 24th 2024

Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB

Hannah Clarke
At 1 month, the mean decrease in the OAB-Q symptom severity subscale score was -31.2 in the 1-injection cohort vs -39.5 in the 10-injection cohort.
Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB
March 18th 2022

Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB

Urology Times staff
“We need to improve the fact that 75% of these patients are untreated [or] unmanaged and frustrated,” says Alexandra Rogers, MD.
New telehealth service provides access to Leva System for urinary incontinence
August 13th 2024

New telehealth service provides access to Leva System for urinary incontinence

Hannah Clarke
Data from a real-world evidence study of the Leva System were recently published in JMIR Formative Research, supporting the safety and effectiveness of the program in the treatment of patients with urinary incontinence.
Trial progresses of SNM device for urge urinary incontinence
July 23rd 2024

Trial progresses of SNM device for urge urinary incontinence

Hannah Clarke
Data from phase 2 of the SANS-UUI trial are expected to support an application to the FDA for approval of the device in patients with urge urinary incontinence.
© 2024 MJH Life Sciences

All rights reserved.